Rhein affects arylamine N‐acetyltransferase activity in Helicobacter pylori from peptic ulcer patients

Arylamine N‐acetyltransferase (NAT) activities with 2‐aminofluorene and p‐aminobenzoic acid were determined in the bacterium Helicobacter pylori collected from peptic ulcer patients. Cytosols or suspensions of H. pylori with or without specific concentrations of rhein co‐treatment showed different percentages of 2‐aminofluorene and p‐aminobenzoic acid acetylation. The data indicate that there was decreased NAT activity associated with increased levels of rhein in H. pylori cytosols. Inhibition of growth studies from H. pylori demonstrated that rhein elicited dose‐dependent bacteriostatic activity in H. pylori cultures: i.e. the greater the concentration of rhein, the greater the inhibition of growth to H. pylori. For the cytosol and intact bacteria examination, the apparent values of Km and Vmax were decreased after co‐treatment with 40 μM rhein. This report is the first demonstration of rhein inhibition of arylamine N‐acetyltransferase activity and rhein inhibition of growth in the bacterium H. pylori. © 1998 John Wiley & Sons, Ltd.

[1]  Jing-Gung Chung,et al.  Emodin-Induced Inhibition of Growth and DNA Damage in the Helicobacter pylori , 1997, Current Microbiology.

[2]  J. M. Lai,et al.  Evidence for arylamine N-acetyltransferase in the nematode Anisakis simplex. , 1996, Cancer letters.

[3]  W. Weber,et al.  Kinetics of acetyl coenzyme A:arylamine N-acetyltransferase from rapid and slow acetylator frog tissues. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[4]  J G Chung,et al.  Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[5]  S. Akimoto,et al.  Biological activities of the intestinal microflora in mice treated with antibiotics or untreated and the effects of the microflora on absorption and metabolic activation of orally administered glutathione conjugates of K-region epoxides of 1-nitropyrene. , 1993, Carcinogenesis.

[6]  S. Tominaga,et al.  A Prospective Study of Atrophic Gastritis and Stomach Cancer Risk , 1992, Japanese journal of cancer research : Gann.

[7]  R. Minchin,et al.  N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. , 1992, Biochemical and biophysical research communications.

[8]  M. Benassi,et al.  Growth inhibition by rhein and lonidamine of human glioma cells in vitro. , 1990, Anticancer research.

[9]  A. Floridi,et al.  Inhibition of protein synthesis in neoplastic cells by rhein. , 1990, Biochemical pharmacology.

[10]  A. Floridi,et al.  Effect of rhein on the glucose metabolism of Ehrlich ascites tumor cells. , 1990, Biochemical pharmacology.

[11]  G. Ferretti,et al.  Diacetylrhein and rhein: in vivo and in vitro effect on lymphocyte membrane fluidity. , 1990, Pharmacological research.

[12]  G. Buck.  Campylobacter pylori and gastroduodenal disease , 1990, Clinical Microbiology Reviews.

[13]  J. Holton,et al.  Campylobacter pylori and gastritis , 1989 .

[14]  B. Marshall,et al.  PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI , 1988, The Lancet.

[15]  S. Tarli,et al.  Rhein: an anthraquinone that modulates superoxide anion production from human neutrophils , 1987, The Journal of pharmacy and pharmacology.

[16]  K. Ilett,et al.  Acetylation phenotype in colorectal carcinoma. , 1987, Cancer research.

[17]  F. Kadlubar,et al.  Role of aromatic amine acetyltransferase in human colorectal cancer. , 1986, Archives of surgery.

[18]  A. Swaak,et al.  Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase. , 1986, Annals of the rheumatic diseases.

[19]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS , 1983, The Lancet.

[20]  J Robinwarren,et al.  UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS , 1983 .

[21]  R. Glashan,et al.  ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER , 1982, The Lancet.

[22]  G. Lower.  Concepts in causality: Chemically induced human urinary bladder cancer , 1982, Cancer.

[23]  P. Mosconi,et al.  A non steroidal anti-inflammatory drug that stimulates prostaglandin release. , 1980, Il Farmaco; edizione scientifica.

[24]  W. Weber,et al.  Inheritance of acetylator phenotype in mice. , 1980, The Journal of pharmacology and experimental therapeutics.

[25]  S. Kim,et al.  Selective potentiation of hyperthermic killing of hypoxic cells by 5-thio-D-glucose. , 1978, Cancer research.

[26]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[27]  Jing-Gung Chung,et al.  Kinetics of acetyl CoA: Arylamine N-acetyltransferase from rapid and slow acetylator fish tissues , 1999 .

[28]  D. Grant,et al.  Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: metabolism and mutagenic activation of aromatic amines. , 1992, Cancer research.

[29]  H. Zanen,et al.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. , 1988, Gastroenterology.

[30]  G. Larsen.  4 – Deconjugation of Biliary Metabolites by Microfloral β-glucuronidases, Sulphatases and Cysteine Conjugate β-lyases and their Subsequent Enterohepatic Circulation , 1988 .

[31]  W. Weber.  The acetylator genes and drug response , 1987 .

[32]  W. Weber,et al.  Kinetics of arylamine N-acetyltransferase in tissues from rapid and slow acetylator mice. , 1987, Carcinogenesis.

[33]  J. Brewer,et al.  A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. , 1982, The Journal of pharmacology and experimental therapeutics.

[34]  R. Grahame,et al.  Preliminary experience with diacetylrhein in the treatment of osteoarthritis. , 1980, Current medical research and opinion.

[35]  P. Sims.  The metabolic activation of chemical carcinogens. , 1980, British medical bulletin.

[36]  W. Cleland,et al.  The statistical analysis of enzyme kinetic data. , 1967, Advances in enzymology and related areas of molecular biology.